10076- MPC-8 MOLECULAR DIAGNOSIS OF MEDULLOBLASTOMA: CHARACTERISTICS OF JAPANESE CASES AND DIAGNOSTIC METHODS FOR WNT MBS.

Abstract BACKGROUND Medulloblastomas have been subdivided into pathological morphological groups, but since 2012, consensus has been reached on four different molecular subgroups, including wingless (WNT)-activated, sonic hedgehog (SHH)-activated, groups 3 and 4, which have been included in the WHO classification since 2016 and have been to date, the era has seen a greater emphasis on molecular genetic diagnosis. Although DNA methylation arrays are used as the Golden Standard in many developed countries, in many Asian countries, including Japan, and in clinical practice in developing countries, the diagnosis of the name and type of disease is often based on pathological findings and immunostaining. WNT MB is known as a group with a particularly good prognosis if treated appropriately, and the reliable diagnosis (salvage) of WNT MB patients without omissions is extremely important for future clinical trials. However, no consensus has yet been reached on the optimal method for correct and leak-free diagnosis. METHODS JPMNG: 267 cases registered since 2012 at 43 facilities in Japan participating in the Japanese Pediatric Molecular Neuro-oncology group (244 cases were analyzed in the final analysis). Molecular genetic diagnosis was performed using Nano string, DNA sequencing, DNA methylation array, etc., to classify the patients into four types. RESULTS The four typing groups were WNT: 39 (16%), SHH: 61 (25%), Group3: 42 (17%) and Group4: 102 (41.8%) cases, respectively. Of these, all cases were positive for (1) CTNNB1 in 39 of 39 cases (100%) and (2) monosomy6 in 35 of 35 cases (100%), especially in the diagnosis of WNT. CONCLUSIONS The molecular genetic features of WNT MB were analyzed from 244 cases of medulloblastoma accumulated at the JPMNG. The diagnosis of WNT MB can be made more conveniently and accurately by utilizing multiple modality approaches, in addition to the use of DNA methylation arrays.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology Advances
Published
2024-11-29
DOI
https://doi.org/10.1093/noajnl/vdae173.053
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

10076- MPC-8 MOLECULAR DIAGNOSIS OF MEDULLOBLASTOMA: CHARACTERISTICS OF JAPANESE CASES AND DIAGNOSTIC METHODS FOR WNT MBS.

Isao Date, Masahiro Nonaka, Yonehiro Kanemura, Ryo Nishikawa et al.
Neuro-Oncology Advances
Glioma Diagnosis and Treatment
article

10076- MPC-8 MOLECULAR DIAGNOSIS OF MEDULLOBLASTOMA: CHARACTERISTICS OF JAPANESE CASES AND DIAGNOSTIC METHODS FOR WNT MBS.

Isao Date, Masahiro Nonaka, Yonehiro Kanemura, Ryo Nishikawa, Shigeki Takada, Junko Hirato, Takeshi Inoue, Asako Katsuma, Masahiro Tanji, Etsuko Yamamoto, Atsushi Sasaki, Tomoko Shofuda, Daisuke Kanematsu, Yoshiki Arakawa, Yohei Mineharu, Yoshinori Kodama, Ema Yoshioka, Motoo Nagane, Koichi Ichimura, Noritaka Sano, Kohichi Go, Yasuhide Makino, Masayuki Mano
article en

Abstract

Abstract BACKGROUND Medulloblastomas have been subdivided into pathological morphological groups, but since 2012, consensus has been reached on four different molecular subgroups, including wingless (WNT)-activated, sonic hedgehog (SHH)-activated, groups 3 and 4, which have been included in the WHO classification since 2016 and have been to date, the era has seen a greater emphasis on molecular genetic diagnosis. Although DNA methylation arrays are used as the Golden Standard in many developed countries, in many Asian countries, including Japan, and in clinical practice in developing countries, the diagnosis of the name and type of disease is often based on pathological findings and immunostaining. WNT MB is known as a group with a particularly good prognosis if treated appropriately, and the reliable diagnosis (salvage) of WNT MB patients without omissions is extremely important for future clinical trials. However, no consensus has yet been reached on the optimal method for correct and leak-free diagnosis. METHODS JPMNG: 267 cases registered since 2012 at 43 facilities in Japan participating in the Japanese Pediatric Molecular Neuro-oncology group (244 cases were analyzed in the final analysis). Molecular genetic diagnosis was performed using Nano string, DNA sequencing, DNA methylation array, etc., to classify the patients into four types. RESULTS The four typing groups were WNT: 39 (16%), SHH: 61 (25%), Group3: 42 (17%) and Group4: 102 (41.8%) cases, respectively. Of these, all cases were positive for (1) CTNNB1 in 39 of 39 cases (100%) and (2) monosomy6 in 35 of 35 cases (100%), especially in the diagnosis of WNT. CONCLUSIONS The molecular genetic features of WNT MB were analyzed from 244 cases of medulloblastoma accumulated at the JPMNG. The diagnosis of WNT MB can be made more conveniently and accurately by utilizing multiple modality approaches, in addition to the use of DNA methylation arrays.

Neuro-Oncology AdvancesVol. 6(Supplement_4)
Pediatric Oncology Group (CA), Kyoto University (JP), Osaka National Hospital (JP)
Partnerships for the goals
Openalex Percentile: Top 62%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.